Picture of Evolus logo

EOLS — Evolus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Evolus Enters Into Licensing Agreement With Symatese To Exclusively Distribute Next-Generation Dermal Fillers In Europe

Dec 20 (Reuters) - Evolus Inc  EOLS.O :
    * EVOLUS ENTERS INTO LICENSING AGREEMENT WITH SYMATESE TO
EXCLUSIVELY DISTRIBUTE NEXT-GENERATION DERMAL FILLERS IN EUROPE
    * EVOLUS INC-EUROPEAN REGULATORY APPROVALS ANTICIPATED IN
SECOND
HALF OF 2024
    * EVOLUS INC-CONTINUES TO EXPECT TO BE FULLY FUNDED TO
PROFITABILITY
    * EVOLUS INC-INITIAL AGREEMENT IS FOR A TERM OF 15 YEARS,
WITH
AUTOMATIC FIVE-YEAR RENEWAL PROVISIONS

Source text for Eikon:  ID:nBw8KsH9ma 
Further company coverage:  EOLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Evolus

See all news